PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2449
https://www.valueinhealthjournal.com/article/S1098-3015(18)35751-6/fulltext
Section Title :
Section Order :
1805
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35751-6&doi=10.1016/j.jval.2018.09.2449